Phentermine-topiramate improved CV risk factors through weight loss - Healio
Phentermine-topiramate improved CV risk factors through weight lossHealioPHOENIX — After 2 years of treatment with phentermine-topiramate extended-release, weight loss of at least 5% resulted in positive effects on obese patients' cardiovascular risk factors, notably hypertension and dyslipidemia, according to data .
Charleston doctor is W.Va.'s top prescriber of hydrocodone - Charleston Gazette
Charleston doctor is W.
Diet Drug Trims Hypertension Too - MedPage Today - MedPage Today
MedPage TodayDiet Drug Trims Hypertension Too - MedPage TodayMedPage TodaySAN FRANCISCO -- The weight loss achieved with extended-release phentermine/topiramate (Qsymia) may also come with blood pressure reduction for hypertensive patients, subanalysis of trial results showed.
Supernus to Present at Two Investor Conferences - MarketWatch (press release)
MarketWatch (press release)Supernus to Present at Two Investor ConferencesMarketWatch (press release)The Company has one approved product for epilepsy, Oxtellar XR (extended release oxcarbazepine), and one tentatively approved product for epilepsy, Trokendi XR (extended release topiramate).